B. Boeve

Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations

I. McKeith, John-Paul Taylor, D. Aarsland, 2022, Translational Neurodegeneration.

Correction: Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations

S. Lewis, I. McKeith, John-Paul Taylor, 2022, Translational neurodegeneration.

RENEWAL: REpurposing study to find NEW compounds with Activity for Lewy body dementia—an international Delphi consensus

I. McKeith, John-Paul Taylor, H. Feldman, 2022, Alzheimer's Research & Therapy.

Diagnosis and management of dementia with Lewy bodies

S Minoshima, J Q Trojanowski, J Hardy, 2005, Neurology.

Association of Physical Activity With Neurofilament Light Chain Trajectories in Autosomal Dominant Frontotemporal Lobar Degeneration Variant Carriers.

L. Petrucelli, J. Kramer, K. Yaffe, 2022, JAMA neurology.

Patterns of Brain Atrophy in Clinical Variants of Frontotemporal Lobar Degeneration

C. Jack, G. Bartzokis, B. Miller, 2013, Dementia and Geriatric Cognitive Disorders.

Mesopontine cholinergic neuron involvement in Lewy body dementia and multiple system atrophy

J. Parisi, E. Benarroch, P. Sandroni, 2008, Neurology.

Severity dependent distribution of impairments in PSP and CBS: Interactive visualizations.

Bruce H. Morimoto, J. Jankovic, C. Jack, 2019, Parkinsonism & related disorders.